Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Rigel Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€3.62
14.07.20
-
15.07.20
-12.15%
15.07.20

buy
Aphria Inc.

Start price
Target price
Perf. (%)
€4.27
14.07.20
€5.85
05.08.20
-5.09%
05.08.20

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
buy
Ipsen S.A.

Start price
Target price
Perf. (%)
€81.00
13.07.20
€95.00
04.11.21
12.32%
05.11.21

Could be worthwhile Investment >10% per year
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€28.65
12.07.20
-
17.10.20
9.93%
17.10.20

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Purple Biotech Ltd. ADR

Start price
Target price
Perf. (%)
€7.10
11.07.20
€6.00
04.11.21
-43.38%
05.11.21

Could be worthwhile Investment >10% per year
Innovative
Good culture
buy
Innoviva Inc.

Start price
Target price
Perf. (%)
€12.30
06.07.20
€17.00
04.11.21
27.64%
05.11.21

buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€28.84
01.07.20
€42.69
08.07.20
-2.30%
08.07.20

Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
Inovio Pharma

Start price
Target price
Perf. (%)
€25.80
30.06.20
-
04.11.21
-72.73%
17.06.21

Probably not worthwhile Investment
PDS Biotechnology Corp.

Start price
Target price
Perf. (%)
€1.73
30.06.20
-
24.10.20
3.47%
24.10.20

buy
Chugai Pharmaceutical Co Ltd

Start price
Target price
Perf. (%)
€49.67
26.06.20
-
31.07.20
-21.88%
31.07.20

buy
Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€49.48
19.06.20
€55.00
04.11.21
12.05%
04.04.21

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
buy
Akero Therapeutics Inc

Start price
Target price
Perf. (%)
€22.00
16.06.20
-
02.07.20
35.45%
02.07.20

buy
AstraZeneca plc

Start price
Target price
Perf. (%)
€92.99
15.06.20
€111.00
04.11.21
18.72%
05.11.21

buy
Immuron

Start price
Target price
Perf. (%)
€14.90
09.06.20
-
10.06.20
-45.64%
10.06.20

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€70.87
08.06.20
€65.00
04.11.21
-18.67%
05.11.21

Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Known brand
buy
Eurobio scientific

Start price
Target price
Perf. (%)
€7.42
06.06.20
€20.00
04.11.21
131.94%
05.11.21

Could be worthwhile Investment >10% per year
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€131.66
06.06.20
€205.00
04.11.21
77.81%
05.11.21

Could be worthwhile Investment >10% per year
buy
Evofem Biosciences Inc.

Start price
Target price
Perf. (%)
€46.05
06.06.20
€45.00
04.11.21
-81.42%
05.11.21

Risky Investment
buy
Lysogene SA

Start price
Target price
Perf. (%)
€2.80
05.06.20
€3.30
04.11.21
-18.39%
24.09.21

Could be worthwhile Investment >10% per year
buy
Hexo Corp.

Start price
Target price
Perf. (%)
€35.28
02.06.20
€42.00
17.06.20
19.05%
17.06.20

Higher risks for its business
buy
Novacyt S.A.

Start price
Target price
Perf. (%)
€3.70
31.05.20
€5.00
04.11.21
-12.32%
04.10.21

Could be worthwhile Investment >10% per year
buy
Nanobiotix

Start price
Target price
Perf. (%)
€8.08
29.05.20
€11.00
04.11.21
9.22%
05.11.21

Could be worthwhile Investment >10% per year
buy
Qualigen Therapeutics Inc.

Start price
Target price
Perf. (%)
€56.20
28.05.20
-
09.07.20
-35.59%
09.07.20

buy
Evofem Biosciences Inc.

Start price
Target price
Perf. (%)
€102.90
25.05.20
€135.00
04.11.21
-86.11%
17.06.21

buy
Aphria Inc.

Start price
Target price
Perf. (%)
€3.70
24.05.20
€5.00
26.06.20
-0.54%
26.06.20

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected